Read + Share
Amedeo Smart
Independent Medical Education
Yamaoka T, Kim YH, Iwatsubo S, Nishimura Y, et al. The Role of Dual Inhibition of EGFR and Vascular Endothelial Growth Factor (Receptor) in the Treatment of NSCLC With EGFR Mutation. J Thorac Oncol 2021;16:e71-e72.PMID: 34426001
Email
LinkedIn
Facebook
Twitter
Privacy Policy